Cipla Shares

Sources also suggest that an investment bank has been hired to advise on the deal and PE firms like Blackstone, Baring Asia among others are in talks to explore a deal. This move comes as a step towards succession planning for the company, they added.

Cipla aims to double India business in five years, looks at innovation in US: CEO Umang Vohra

In an exclusive interview with CNBC-TV18, Umang Vohra said that the pharma major is looking at China, Brazil, South Africa, and Australia as key markets, apart from India

Big Story | Cipla, Hetero get regulator nod for Remdesivir: What this means for COVID-19 patients

Remdesivir has emerged as one of the most promising drug candidates in the treatment of COVID-19

Cipla falls 3% post below expected Q2 numbers

Cipla had yesterday reported a consolidated net profit of Rs 298.68 crore for the quarter ended September on account of robust sales in domestic market. The company had posted a net profit of Rs 358.06 crore during the same period of previous fiscal.